An ovine septic shock model of live bacterial infusion

Nchafatso G. Obonyo, Sainath Raman, Jacky Y. Suen, Kate M. Peters, Minh-Duy Phan, Margaret R. Passmore, Mahe Bouquet, Emily S. Wilson, Kieran Hyslop, Chiara Palmieri, Nicole White, Kei Sato, Samia M. Farah, Lucia Gandini, Keibun Liu, Gabriele Fior, Silver Heinsar, Shinichi Ijuin, Sun Kyun Ro, Gabriella Abbate, Carmen Ainola, Noriko Sato, Brooke Lundon, Sofia Portatadino, Reema H. Rachakonda, Bailey Schneider, Amanda Harley, Louise E. See Hoe, Mark A. Schembri, Gianluigi Li Bassi & John F. Fraser. DOI: 10.1186/s40635-024-00684-x

Abstract: Escherichia coli is the most common cause of human bloodstream infections and bacterial sepsis/septic shock. However, translation of preclinical septic shock resuscitative therapies remains limited mainly due to low-fidelity of available models in mimicking clinical illness. To overcome the translational barrier, we sought to replicate sepsis complexity by creating an acutely critically-ill preclinical bacterial septic shock model undergoing active 48-h intensive care management.

Previous
Previous

The role of TandemHeart™ combined with ProtekDuo™ as right ventricular support device

Next
Next

Prevalence and Management of Oral Intake Restrictions in Critically Ill Patients